You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 12, 2025

Profile for Chile Patent: 2020001899


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Chile Patent: 2020001899

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
⤷  Get Started Free Feb 1, 2039 Novo RYBELSUS semaglutide
⤷  Get Started Free Feb 1, 2039 Novo RYBELSUS semaglutide
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Detailed Analysis of Chile Drug Patent CL2020001899: Scope, Claims, and Patent Landscape

Last updated: July 30, 2025


Introduction

The patent CL2020001899, filed and granted in Chile, pertains to a pharmaceutical invention designed to secure exclusive rights over a specific drug, its composition, or its therapeutic use. Analyzing its scope and claims provides vital insights into its strength, coverage, and position within the global patent landscape. This report offers a comprehensive review, emphasizing the patent's claims, scope, and the surrounding patent environment pertinent to this innovation.


Patent Overview

Patent Number: CL2020001899
Filing Date: Not explicitly specified here but presumed to be around 2020 based on the number format.
Grant Date: Pending or granted status must be confirmed via the Chilean National Institute of Industrial Property (INAPI) database.
Applicant: Typically pharmaceutical companies or research institutions; actual owner details would be sourced from INAPI or the official certificate.
Patent Type: Likely a pharmaceutical composition, method of treatment, or an innovative drug formulation, considering usual patent types in the sector.


Scope of the Patent

The scope of a pharmaceutical patent fundamentally defines the territorial and technological boundaries of exclusivity. It encompasses the subject matter over which the patent claims protection, including compounds, formulations, manufacturing processes, or therapeutic methods.

Scope of Protection

  • Chemical Composition and Formulation:
    The patent likely claims a specific chemical compound, its salt forms, derivatives, or pharmaceutical formulations. This scope covers the active ingredients and their stable combinations necessary for therapeutic activity.

  • Method of Manufacturing:
    If the patent includes synthesis processes or specific manufacturing steps, this broadens protection to process-related innovations, preventing third parties from using similar methods.

  • Therapeutic Use:
    Claims may extend to novel therapeutic indications or methods of treatment, conferring a use patent. Such claims impact patent strength by covering the use aspect explicitly.

  • Combination and Delivery Systems:
    Inclusion of drug delivery mechanisms, such as controlled-release formulations or targeted delivery, further extends the patent’s scope, especially if these innovations improve drug efficacy or safety.

In Chile, patent claims must be clear, concise, and supported by a description. The scope’s breadth relies heavily on how broadly the claims are drafted; broad claims bolster protection but may face narrowing during examination.


Claims Analysis

The patent’s claims define its core legal boundaries. Typical claims in a pharmaceutical patent include:

  • Independent Claims:
    These establish the fundamental invention—usually a specific chemical compound or a unique formulation. For example, a claim might cover a chemical entity with specific substituents exhibiting particular pharmacokinetics.

  • Dependent Claims:
    These narrow the scope, referencing the independent claim and adding features like specific dosages, combinations with other agents, or particular administration routes.

Evaluation of Claim Strength and Breadth:

  • Scope Breadth:
    Broad claims covering a novel compound or unique formulation have better market potential but are more susceptible to legal challenges or prior art rejections. Narrow claims offer less expansive protection but are easier to defend.

  • Novelty and Inventive Step:
    For claims to be valid, the innovation must be non-obvious and novel in light of existing prior art. Chilean patent law, aligned with international standards, evaluates these parameters meticulously.

  • Claim Specifications:
    The claims should be supported by a detailed description demonstrating utility, preparation methods, and comparative advantages over existing treatments. The clarity of claims influences enforceability and scope.

Due to the confidential nature of pending patents and the documentation typically not fully accessible outside the patent office, a precise analysis of the specific claims is predicated on examining the official granted patent document.


Patent Landscape in Chile and Globally

Understanding the patent landscape requires contextualizing CL2020001899 within existing patents, patent families, and legal challenges.

Chile’s Pharmaceutical Patent Environment

  • Chile's patent system aligns with the TRIPS Agreement, emphasizing novelty, inventive step, and industrial applicability [1].
  • Pharmaceutical patents are scrutinized rigorously, especially regarding novelty and inventive step.
  • Local patent laws permit patent term protection for 20 years from filing, ensuring long-term market exclusivity.

Global Patent Trends

  • Patent Families and Priority:
    Many drugs are filed as part of international patent families through Patent Cooperation Treaty (PCT) applications, giving a broader geographic scope. An analysis would consider whether CL2020001899 is part of such a family, which can impact its strategic value.

  • Patent Challenges and Litigation:
    The landscape involves navigating patent landscapes for existing patents in key markets like the US, Europe, and Latin America. Drugs facing generic competition often see patent challenges, especially if the patents are narrow or weak.

  • Overlap with Existing Patents:
    Similar compounds or formulations claimed in other jurisdictions could limit the scope or enforceability in Chile. Conversely, innovative claims that are distinctive can offer a strong competitive advantage.

Patent Landscape Analysis

  • The patent landscape reveals increasing filings in the pharmaceutical sector, particularly for biologics, targeted therapies, and drug delivery systems.
  • Chile’s geographical position and bilateral agreements influence patent filings, especially from multinational pharmaceutical companies.

Implications for Stakeholders

  • Innovators:
    A well-drafted patent broad in claims could secure market exclusivity in Chile, providing a competitive edge and protecting investments into R&D.

  • Generic Manufacturers:
    They must scrutinize the claims meticulously to identify potential design-around opportunities or patent invalidation strategies.

  • Legal and Patent Strategists:
    Continuous monitoring of related patents and legal developments is essential, given the public nature of patents and possible prior art challenges.


Conclusion

The Chilean patent CL2020001899 appears to encompass a specific pharmaceutical compound, formulation, or method, with the potential to provide a strong legal monopoly within Chile's territory. Its claims' breadth, scope, and legal robustness largely determine its strategic value. The patent landscape indicates active competition among innovator and generic firms, emphasizing the importance of a robust patent strategy aligned with international standards.


Key Takeaways

  • Claim Breadth Matters: Broad, well-supported claims extending to chemical structure, formulation, and use provide stronger protection but require robust inventive step arguments.
  • Strategic Patent Positioning: Integration into global patent families amplifies market protection and prevents workarounds.
  • Patent Validity and Enforcement: Continuous monitoring of prior art, legal challenges, and patent examination updates are critical to maintaining patent strength.
  • Market and Legal Risks: Patent landscapes are dynamic; theoretical protection must be validated against evolving prior art and litigation trends.
  • Alignment with International Laws: Compliance with TRIPS and local regulations ensures enforceability and strategic leverage.

FAQs

  1. What is the significance of the claims in patent CL2020001899?
    The claims define the legal boundary of the patent, determining what constitutes infringement and what innovations are protected, thus critical for enforcement and commercial strategy.

  2. How does the patent landscape influence the value of this Chilean patent?
    The surrounding patent environment determines the patent’s strength, the likelihood of infringement disputes, and potential for licensing or litigation.

  3. Can this patent block generic competitors in Chile?
    Yes, if claims are broad and valid, they can prevent generic manufacturers from marketing similar products during the patent's term.

  4. What strategies can competitors use to navigate or challenge this patent?
    Competitors can analyze prior art to challenge validity, seek licensing agreements, or develop alternative formulations that circumvent claims.

  5. How does Chile's patent law impact pharmaceutical patent enforcement?
    Chile’s legal framework emphasizes novelty, inventive step, and clear claims, ensuring balanced protection for innovators and access to generics after patent expiry.


References

[1] TRIPS Agreement, World Trade Organization.
[2] Chilean Patent Law (Law No. 19,039).
[3] INAPI Patent Database.

(Note: Specific claim language and patent documentation should be reviewed directly from the Chilean patent office for precise legal and technical analysis.)

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.